TScan Therapeutics to hold special meeting
- Scheduled for November 20, 2026
- Includes reverse stock split proposal
- Board recommends approval of proposals
TCRX
TScan Therapeutics, Inc. SEC filings
Every EDGAR filing for TScan Therapeutics, Inc. (TCRX), newest first, with AI summaries and stories.
- Ticker
- TCRX
- CIK
- 1783328
- Sector
- Biotech and pharma
- Latest filing
- 2d
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Also: 2 grants or exercises.
Filings
PRE 14ATScan Therapeutics, Inc.TCRXLIVE 8-KTScan Therapeutics, Inc.TCRXLIVE TScan Therapeutics reports director departures
- Garry Nicholson and Gabriela Gruia resigned from TCRX's board on 2026-10-13
- Stephen Biggar and R. Keith Woods were appointed to the NCG Committee
- The Audit Committee now includes R. Keith Woods
4TScan Therapeutics, Inc.TCRXLIVE 2 insider filings
Zoran Zdraveski, insider filing for TCRX
Show all 2
- 4Insider filing for TCRX
- 4Insider filing for TCRX
Zoran Zdraveski
8-KTScan Therapeutics, Inc.TCRXLIVE SCHEDULE 13GTScan Therapeutics, Inc.TCRXLIVE Ownership stake disclosure by Readout Capital, LP
Readout Capital, LP, filed by
8-KTScan Therapeutics, Inc.TCRXLIVE 8-KTScan Therapeutics, Inc.TCRXLIVE 8-KTScan Therapeutics, Inc.TCRXLIVE SCHEDULE 13G/ATScan Therapeutics, Inc.TCRXLIVE 2 13G filings
Ownership stake disclosure by Lynx1 Capital Management LP (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
Lynx1 Capital Management LP, filed by
8-KTScan Therapeutics, Inc.TCRXLIVE 10-QTScan Therapeutics, Inc.TCRXLIVE 8-KTScan Therapeutics, Inc.TCRXLIVE 4TScan Therapeutics, Inc.TCRXLIVE 6 insider filings
Julian Baker, insider filing for TCRX
Show all 6
- 4Insider filing for TCRX
- 4Insider filing for TCRX
- 4Insider filing for TCRX
- 4Insider filing for TCRX
- 4Insider filing for TCRX
- 4Insider filing for TCRX
Julian Baker, reporting · Felix Baker, reporting · +4 more
8-KTScan Therapeutics, Inc.TCRXLIVE SCHEDULE 13G/ATScan Therapeutics, Inc.TCRXLIVE Ownership stake disclosure by BIOTECHNOLOGY VALUE FUND L P (amended)
BIOTECHNOLOGY VALUE FUND L P, filed by
10-QTScan Therapeutics, Inc.TCRXLIVE 8-KTScan Therapeutics, Inc.TCRXLIVE ARSTScan Therapeutics, Inc.TCRXLIVE DEF 14ATScan Therapeutics, Inc.TCRXLIVE PRE 14ATScan Therapeutics, Inc.TCRXLIVE 8-KTScan Therapeutics, Inc.TCRXLIVE S-8TScan Therapeutics, Inc.TCRXLIVE 10-KTScan Therapeutics, Inc.TCRXLIVE 8-KTScan Therapeutics, Inc.TCRXLIVE 4TScan Therapeutics, Inc.TCRXLIVE 5 insider filings
Jason Amello, insider filing for TCRX
Show all 5
- 4Insider filing for TCRX
- 4Insider filing for TCRX
- 4Insider filing for TCRX
- 4Insider filing for TCRX
- 4Insider filing for TCRX
Jason Amello, reporting
8-KTScan Therapeutics, Inc.TCRXLIVE 4TScan Therapeutics, Inc.TCRXLIVE Weston Nichols, insider filing for TCRX
Weston Nichols, reporting · Lynx1 Capital Management LP, reporting
8-KTScan Therapeutics, Inc.TCRXLIVE 10-QTScan Therapeutics, Inc.TCRXLIVE 8-KTScan Therapeutics, Inc.TCRXLIVE 8-KTScan Therapeutics, Inc.LIVE